Upgrades/Downgrades
Updated: 10-Aug-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Sionna Therapeutics | SION | RBC Capital Mkts | Underperform » Sector Perform | $5 | |
| United Micro | UMC | Arete | Neutral » Buy | ||
| Sezzle | SEZL | TD Cowen | Hold » Buy | $165 | |
| Sandisk | SNDK | Argus | Hold » Buy | ||
| Protagonist Therapeutics | PTGX | Goldman | Neutral » Buy | $186 | |
| NetApp | NTAP | Morgan Stanley | Underweight » Equal-Weight | $173 | |
| LSB Industries | LXU | RBC Capital Mkts | Sector Perform » Outperform | $13 | |
| Lincoln Electric | LECO | Morgan Stanley | Underweight » Equal-Weight | $283 | |
| James Hardie | JHX | Barclays | Equal Weight » Overweight | $35 | |
| Hewlett Packard Enterprise | HPE | Morgan Stanley | Equal-Weight » Overweight | $69 | |
| FirstCash | FCFS | Loop Capital | Hold » Buy | $255 | |
| Everpure | P | Morgan Stanley | Equal-Weight » Overweight | $108 | |
| Everpure | P | Susquehanna | Neutral » Positive | $120 | |
| Dick's Sporting Goods | DKS | Wells Fargo | Equal Weight » Overweight | $240 | |
| B2Gold | BTG | Scotiabank | Sector Perform » Sector Outperform | ||
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Sionna Therapeutics | SION | BTIG Research | Buy » Neutral | ||
| Monday.com | MNDY | CapitalOne | Overweight » Equal Weight | $95 | |
| Sionna Therapeutics | SION | Guggenheim | Buy » Neutral | ||
| Sionna Therapeutics | SION | Citizens | Mkt Outperform » Mkt Perform | ||
| The Trade Desk | TTD | BNP Paribas Exane | Neutral » Underperform | $10 | |
| Sionna Therapeutics | SION | Raymond James | Strong Buy » Mkt Perform | ||
| Sionna Therapeutics | SION | Wedbush | Outperform » Neutral | $5 | |
| The Trade Desk | TTD | DA Davidson | Buy » Neutral | ||
| Sionna Therapeutics | SION | Stifel | Buy » Hold | $7 | |
| The Trade Desk | TTD | HSBC Securities | Hold » Reduce | $10 | |
| Teradata | TDC | Morgan Stanley | Overweight » Equal-Weight | $29 | |
| Spectrum Brands | SPB | RBC Capital Mkts | Outperform » Sector Perform | $92 | |
| Samsara | IOT | Piper Sandler | Overweight » Neutral | $40 | |
| MapLight Therapeutics | MPLT | UBS | Buy » Neutral | $13 | |
| Kennametal | KMT | Morgan Stanley | Equal-Weight » Underweight | $27 | |
| Interparfums | IPAR | Goldman | Buy » Neutral | $129 | |
| Interparfums | IPAR | TD Cowen | Buy » Hold | $120 | |
| i3 Verticals | IIIV | The Benchmark Company | Buy » Hold | ||
| Global-E Online | GLBE | Morgan Stanley | Overweight » Equal-Weight | $44 | |
| Doximity | DOCS | Wells Fargo | Equal Weight » Underweight | $18 | |
| Domino's Pizza | DPZ | Loop Capital | Buy » Hold | $353 | |
| Compass Minerals | CMP | JP Morgan | Neutral » Underweight | $27 | |
| Cognex | CGNX | HSBC Securities | Buy » Hold | $65 | |
| Chemours | CC | UBS | Buy » Neutral | $18 | |
| BioLife Solutions | BLFS | The Benchmark Company | Buy » Hold | ||
| ATS Corp | ATS | TD Securities | Buy » Hold | ||
| ARKO Corp. | ARKO | Raymond James | Strong Buy » Outperform | $7 | |
| Apple | AAPL | Jefferies | Hold » Underperform | $263.66 | |
| Amrize | AMRZ | RBC Capital Mkts | Sector Perform » Underperform | $48 | |
| Akamai Tech | AKAM | HSBC Securities | Buy » Hold | $123 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Standard Nuclear | STDN | Goldman | Buy | $18 | |
| Standard Nuclear | STDN | RBC Capital Mkts | Outperform | $11 | |
| Standard Nuclear | STDN | Stifel | Buy | $16 | |
| Standard Nuclear | STDN | UBS | Buy | $14 | |
| Standard Nuclear | STDN | Evercore ISI | Outperform | $17 | |
| Standard Nuclear | STDN | Barclays | Overweight | $17 | |
| Standard Nuclear | STDN | William Blair | Outperform | ||
| Standard Nuclear | STDN | BofA Securities | Buy | $15 | |
| Kestra Medical Technologies | KMTS | JP Morgan | Overweight | $30 | |
| Guidewire Software | GWRE | Piper Sandler | Overweight | $210 | |
| Csquare | CSQR | BMO Capital Markets | Outperform | $26 | |
| Csquare | CSQR | Morgan Stanley | Overweight | $26 | |
| Csquare | CSQR | RBC Capital Mkts | Outperform | $24 | |
| Csquare | CSQR | JP Morgan | Neutral | $24 | |
| Csquare | CSQR | Wells Fargo | Overweight | $25 | |
| Csquare | CSQR | TD Cowen | Buy | $28 | |
| Csquare | CSQR | BofA Securities | Buy | $46 | |
| Csquare | CSQR | Jefferies | Buy | $29 | |
| Csquare | CSQR | Bernstein | Outperform | $27 | |
| Csquare | CSQR | Scotiabank | Sector Outperform | $30 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Western Alliance Bancorp | WAL | Wells Fargo | Equal Weight | $90 | |
| UMB Financial Corporation | UMBF | Wells Fargo | Equal Weight | $160 | |
| Pinnacle Finl | PNFP | Wells Fargo | Equal Weight | $118 | |
| OFG Bancorp | OFG | Wells Fargo | Equal Weight | $55 | |
| Forbright | FRBT | Wells Fargo | Overweight | $22 | |
| First Horizon | FHN | Wells Fargo | Equal Weight | $28 | |
| First Bancorp | FBP | Wells Fargo | Overweight | $33 | |
| F.N.B. Corp | FNB | Wells Fargo | Overweight | $22 | |
| East West Banc | EWBC | Wells Fargo | Overweight | $155 | |
| Columbia Banking | COLB | Wells Fargo | Equal Weight | $34 | |
| Commerce Bancshares | CBSH | Wells Fargo | Equal Weight | $63 | |
| BOK Financial | BOKF | Wells Fargo | Equal Weight | $148 | |
| BankUnited | BKU | Wells Fargo | Overweight | $54 | |
| Bank OZK | OZK | Wells Fargo | Equal Weight | $56 | |
| Banc of California | BANC | Wells Fargo | Overweight | $23 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| First Interstate Bancsystem | FIBK | Wells Fargo | Underweight | $34 | |
| Uber | UBER | Jefferies | Buy | $100 » $110 | |
| Spectrum Brands | SPB | Monness Crespi & Hardt | Buy | $86 » $105 | |
| Workday | WDAY | Monness Crespi & Hardt | Buy | $150 » $202 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |